Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Heron Therapeutics Return on Investment 2010-2023 | HRTX

Current and historical return on investment (ROI) values for Heron Therapeutics (HRTX) over the last 10 years.
  
Heron Therapeutics ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2023-12-31 $-0.11B $0.14B -82.40%
2023-09-30 $-0.12B $0.15B -86.18%
2023-06-30 $-0.14B $0.11B -94.00%
2023-03-31 $-0.14B $0.14B -96.00%
2022-12-31 $-0.17B $0.16B -109.61%
2022-09-30 $-0.21B $0.17B -119.03%
2022-06-30 $-0.22B $0.13B -109.69%
2022-03-31 $-0.23B $0.17B -93.76%
2021-12-31 $-0.22B $0.23B -108.46%
2021-09-30 $-0.23B $0.27B -155.98%
2021-06-30 $-0.23B $0.31B -299.03%
2021-03-31 $-0.23B inf%
2020-12-31 $-0.23B inf%
2020-09-30 $-0.23B inf%
2020-06-30 $-0.20B inf%
2020-03-31 $-0.20B inf%
2019-12-31 $-0.21B inf%
2019-09-30 $-0.20B inf%
2019-06-30 $-0.21B inf%
2019-03-31 $-0.20B inf%
2018-12-31 $-0.18B inf%
2018-09-30 $-0.20B inf%
2018-06-30 $-0.19B -1193.85%
2018-03-31 $-0.20B -495.60%
2017-12-31 $-0.19B -249.52%
2017-09-30 $-0.18B $0.07B -211.76%
2017-06-30 $-0.19B $0.09B -218.08%
2017-03-31 $-0.19B $0.15B -302.01%
2016-12-31 $-0.17B $0.03B -709.28%
2016-09-30 $-0.16B $0.07B -911.76%
2016-06-30 $-0.13B inf%
2016-03-31 $-0.11B inf%
2015-12-31 $-0.10B inf%
2015-09-30 $-0.08B inf%
2015-06-30 $-0.08B inf%
2015-03-31 $-0.08B inf%
2014-12-31 $-0.07B inf%
2014-09-30 $-0.07B inf%
2014-06-30 $-0.06B inf%
2014-03-31 $-0.06B inf%
2013-12-31 $-0.06B inf%
2013-09-30 $-0.05B inf%
2013-06-30 $-0.04B inf%
2013-03-31 $-0.03B inf%
2012-12-31 $-0.02B inf%
2012-09-30 $-0.02B inf%
2012-06-30 $-0.02B -357.89%
2012-03-31 $-0.02B -157.89%
2011-12-31 $-0.01B -115.79%
2011-09-30 $-0.01B $0.02B -94.74%
2011-06-30 $-0.01B $0.02B -147.37%
2011-03-31 $-0.01B inf%
2010-12-31 $-0.01B inf%
2010-09-30 $-0.01B inf%
2010-06-30 $-0.01B inf%
2010-03-31 $-0.01B inf%
2009-12-31 $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.432B $0.127B
Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.863B 31.25
Chugai Pharmaceutical (CHGCY) Japan $52.640B 23.53
Takeda Pharmaceutical (TAK) Japan $42.029B 6.81
Merck (MKGAF) Germany $21.814B 20.58
Astellas Pharma (ALPMY) Japan $18.187B 28.71
Neurocrine Biosciences (NBIX) United States $14.410B 39.45
Sandoz Group AG (SDZNY) Switzerland $14.309B 0.00
Shionogi (SGIOY) Japan $14.080B 12.63
United Therapeutics (UTHR) United States $11.808B 12.59
Catalent (CTLT) United States $10.230B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.673B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.011B 7.71
Revolution Medicines (RVMD) United States $6.629B 0.00
Ionis Pharmaceuticals (IONS) United States $5.966B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Madrigal Pharmaceuticals (MDGL) United States $4.639B 0.00
Alpine Immune Sciences (ALPN) United States $4.238B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.753B 0.00
Summit Therapeutics (SMMT) United States $3.728B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.097B 0.00
Corcept Therapeutics (CORT) United States $2.549B 23.09
Indivior (INDV) United States $2.440B 11.57
PTC Therapeutics (PTCT) United States $2.438B 0.00
Dyne Therapeutics (DYN) United States $2.241B 0.00
Ardelyx (ARDX) United States $2.166B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.063B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.999B 11.42
NewAmsterdam Pharma (NAMS) Netherlands $1.982B 0.00
Evotec AG (EVO) Germany $1.821B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.816B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.787B 18.46
Avadel Pharmaceuticals (AVDL) Ireland $1.647B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.594B 27.91
Soleno Therapeutics (SLNO) United States $1.564B 0.00
Xencor (XNCR) United States $1.494B 0.00
4D Molecular Therapeutics (FDMT) United States $1.371B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.271B 11.94
Pacira BioSciences (PCRX) United States $1.233B 11.73
Collegium Pharmaceutical (COLL) United States $1.220B 7.51
Enliven Therapeutics (ELVN) United States $1.161B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.085B 0.00
Cronos Group (CRON) Canada $1.009B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.974B 0.00
Cassava Sciences (SAVA) United States $0.944B 0.00
ARS Pharmaceuticals (SPRY) United States $0.918B 0.00
Ocular Therapeutix (OCUL) United States $0.918B 0.00
Relay Therapeutics (RLAY) United States $0.895B 0.00
USANA Health Sciences (USNA) United States $0.859B 13.94
Sage Therapeutics (SAGE) United States $0.781B 0.00
Siga Technologies (SIGA) United States $0.744B 9.51
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.730B 0.00
Savara (SVRA) United States $0.727B 0.00
Silence Therapeutics (SLN) United Kingdom $0.664B 0.00
Lyell Immunopharma (LYEL) United States $0.648B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.615B 0.00
Exscientia (EXAI) United Kingdom $0.601B 0.00
ProKidney (PROK) United States $0.548B 0.00
OmniAb (OABI) United States $0.538B 0.00
Larimar Therapeutics (LRMR) United States $0.519B 0.00
Verve Therapeutics (VERV) United States $0.517B 0.00
Altimmune (ALT) United States $0.515B 0.00
KalVista Pharmaceuticals (KALV) United States $0.514B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.463B 0.00
Esperion Therapeutics (ESPR) United States $0.449B 0.00
Lexeo Therapeutics (LXEO) United States $0.442B 0.00
Korro Bio (KRRO) United States $0.433B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.418B 0.00
Bioventus (BVS) United States $0.405B 15.52
Tourmaline Bio (TRML) United States $0.405B 0.00
Harrow (HROW) United States $0.387B 0.00
Black Diamond Therapeutics (BDTX) United States $0.378B 0.00
Nature's Sunshine Products (NATR) United States $0.360B 22.76
Verrica Pharmaceuticals (VRCA) United States $0.325B 0.00
Organogenesis (ORGO) United States $0.322B 61.00
Aquestive Therapeutics (AQST) United States $0.308B 0.00
Fractyl Health (GUTS) United States $0.305B 0.00
Nanobiotix S.A (NBTX) France $0.302B 0.00
ESSA Pharma (EPIX) Canada $0.302B 0.00
Akebia Therapeutics (AKBA) United States $0.293B 0.00
Eliem Therapeutics (ELYM) United States $0.283B 0.00
Xeris Biopharma Holdings (XERS) United States $0.279B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.277B 0.00
Nektar Therapeutics (NKTR) United States $0.275B 0.00
Pyxis Oncology (PYXS) United States $0.258B 0.00
Adherex Technologies (FENC) United States $0.255B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
Metagenomi (MGX) United States $0.242B 0.00
Avita Medical (RCEL) United States $0.242B 0.00
Foghorn Therapeutics (FHTX) United States $0.240B 0.00
Conduit Pharmaceuticals (CDT) United States $0.237B 0.00
Zevra Therapeutics (ZVRA) United States $0.225B 0.00
Century Therapeutics (IPSC) United States $0.218B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.209B 0.00
Galectin Therapeutics (GALT) United States $0.207B 0.00
Acrivon Therapeutics (ACRV) United States $0.189B 0.00
Telomir Pharmaceuticals (TELO) United States $0.186B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
MediWound (MDWD) Israel $0.180B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.162B 0.00
Prelude Therapeutics (PRLD) United States $0.156B 0.00
Incannex Healthcare (IXHL) Australia $0.152B 0.00
CytoDyn (CYDY) United States $0.147B 0.00
Regulus Therapeutics (RGLS) United States $0.146B 0.00
Elite Pharmaceuticals (ELTP) United States $0.144B 13.50
FibroGen (FGEN) United States $0.136B 0.00
Cardiol Therapeutics (CRDL) Canada $0.135B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.134B 2.81
VAXART, INC (VXRT) United States $0.131B 0.00
Karyopharm Therapeutics (KPTI) United States $0.128B 0.00
Inotiv (NOTV) United States $0.121B 0.00
OptiNose (OPTN) United States $0.116B 0.00
Relmada Therapeutics (RLMD) United States $0.115B 0.00
PMV Pharmaceuticals (PMVP) United States $0.112B 0.00
Citius Pharmaceuticals (CTXR) United States $0.109B 0.00
Assertio Holdings (ASRT) United States $0.106B 4.83
Aclaris Therapeutics (ACRS) United States $0.096B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
AlloVir (ALVR) United States $0.092B 0.00
ProPhase Labs (PRPH) United States $0.091B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Jaguar Animal Health (JAGX) United States $0.082B 0.00
Tempest Therapeutics (TPST) United States $0.080B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.078B 0.00
SCYNEXIS (SCYX) United States $0.070B 1.04
Journey Medical (DERM) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.065B 0.00
Champions Oncology (CSBR) United States $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.055B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Unicycive Therapeutics (UNCY) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
JanOne (JAN) United States $0.039B 0.00
DURECT (DRRX) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
CASI Pharmaceuticals (CASI) China $0.035B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
Surrozen (SRZN) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Lipocine (LPCN) United States $0.027B 0.00
Nutriband (NTRB) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lyra Therapeutics (LYRA) United States $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.021B 1.05
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
CERo Therapeutics Holdings (CERO) United States $0.019B 0.00
Aptorum Group (APM) United Kingdom $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Mannatech (MTEX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Inhibikase Therapeutics (IKT) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Acutus Medical (AFIB) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.27
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.58